Kenneth Lin

Kenneth Lin

Director/Board Member bij ANEBULO PHARMACEUTICALS, INC.

Vermogen: - $ op 31-03-2024

51 jaar
Finance
Health Technology
Consumer Services

Profiel

Kenneth S.
Lin
was the founder of Ab Initio Biotherapeutics, Inc. founded in 2015, where he held the position of President & Chief Executive Officer until 2019.
Currently, he is an Independent Director at Anebulo Pharmaceuticals, Inc. since 2021 and an Advisor at Tarrant Capital IP LLC since 2008.
Dr. Lin's former positions include Director at Vibrynt, Inc. and Conventus Orthopaedics, Inc., VP-Corporate Development & Investor Relations at Ulthera, Inc. from 2012 to 2014, Research Associate at Goldman Sachs & Co. LLC from 2000 to 2002, Associate at J.P.
Morgan Partners LLC and Panorama Capital LLC, and Vice President at TPG, Inc. from 2008 to 2012.
Dr. Lin's education includes an undergraduate degree from Stanford University in 1994 and a doctorate degree from Case Western Reserve University in 1999.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
30-09-2023 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Kenneth Lin

BedrijvenFunctieBegin
ANEBULO PHARMACEUTICALS, INC. Director/Board Member 01-02-2021
Corporate Officer/Principal 13-06-2012
Alle actieve functies van Kenneth Lin

Eerdere bekende functies van Kenneth Lin

BedrijvenFunctieEinde
Chief Executive Officer 01-07-2019
Investor Relations Contact 01-07-2014
TPG INC. Corporate Officer/Principal 01-06-2012
Corporate Officer/Principal 31-12-2007
Analyst-Equity 31-12-2002
Ervaring van Kenneth Lin in detail bekijken

Opleiding van Kenneth Lin

Stanford University Undergraduate Degree
Case Western Reserve University Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Kenneth Lin in detail bekijken

Connecties

100 +

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
ANEBULO PHARMACEUTICALS, INC.

Health Technology

TPG INC.

Finance

Bedrijven in privébezit8

Health Technology

Health Technology

Health Services

Finance

Finance

Finance

Finance

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Kenneth Lin